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Abstract 
 Proteins translated by ribosomes in the rough endoplasmic reticulum (ER) are 
transported to the organelles or the plasma membrane via the Golgi apparatus. 
Further, some organisms uptake the nutrients from the extracellular environment by 
endocytosis or phagocytosis and utilize for its energy production. This sequential 
protein transport system, called membrane trafficking, is regulated by Rab small 
GTPases as a molecular switch. Rab small GTPases are the member of the Ras 
superfamily, and promote membrane fusion in the membrane trafficking. 
 Entamoeba histolytica, an intestinal protozoan parasite, engulfs bacteria and host 
cells. E. histolytica displays two distinct life stages: the dormant cyst and proliferative 
trophozoite stages. Infection initiates by oral ingestion of cysts. Cysts are 
differentiated to trophozoites (excystation) in the small intestinal lumen, and 
trophozoites colonize host intestinal tissues via the galactose and 
N-acetyl-D-galactosamine (Gal/GalNAc)–specific lectin. After the colonization, E. 
histolytica secretes protease, cysteine protease, and invades into the host intestinal 
tissues. In these events, Rab GTPases play pivotal roles in membrane fusion and 
regulated transport.  
 Interestingly, E. histolytica codes more than 100 Rab genes in their genome, whereas 
Homo sapiens possesses around 60 Rab genes despite of their multicellularity. 
Biological functions of most of Rab GTPases are still poorly understood in E. 
histolytica. In the previous phagosomal proteome analysis, colleagues of my lab 
identified 14 Rab proteins from the amoebic phagosomes. Among them, a homologue 
of Rab8, which plays a role in trafficking from the trans-Golgi network to the plasma 
membrane in Homo sapiens Rab8A or Saccharomyces cerevisiae ortholog, Sec3p, was 
identified. There is no report that Rab8 regulates phagocytosis directly in these 
organisms, while I here demonstrated that down-regulation of EhRab8A by small 
antisense RNA-mediated transcriptional gene silencing remarkably reduced 
adherence and phagocytosis of erythrocytes, bacteria, and carboxylated latex beads. 
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Further, surface biotinylation followed by SDS-PAGE analysis revealed that the 
surface expression of several proteins presumably involved in target recognition was 
reduced in the EhRab8A gene silenced strain. However the transport pathway and 
cargo proteins were unveiled. Here, I aimed to clarify the transport pathway and the 
machinery regulated by EhRab8A. 
 First, to confirm whether Rab8A functions for the phagocytosis by regulating the 
surface proteins, I established Rab8A overexpressed strain and 
dominant-negative/active strain and access the phagocytosis. Overexpression of 
wild-type EhRab8A augmented phagocytosis whereas expression of the 
dominant-negative form of EhRab8A resulted in reduced phagocytosis. These results 
indicated that EhRab8A regulates transport of surface receptor(s) for the prey from 
the ER to the plasma membrane. Next, I performed the localization analysis to 
determine the transport pathway of EhRab8A. I referred for the human Rab8 
localization; Rab8 carries the traffic from the TGN to the plasma membrane with 
Rab11. The localization of EhRab11B was already reported, which is localized to the 
TGN as well as in other eukaryotes, however the localization of EhRab8A was 
completely differed from that of EhRab11B. EhRab8A was localized to the ER with 
EhBiP, which is an ER-residing chaperon protein, but the different compartment from 
EhSec13, which is one of a component of the COPII vesicle. According to these results, 
it was clarified that EhRab8A regulate the surface protein transport from the ER to 
the plasma membrane. 
 Second, to determine the further function or cargo protein of EhRab8A, the 
investigation of the binding protein of EhRab8A was accomplished. The Blue-Native 
Polyacrylamide gel Electrophoresis (BN-PAGE) following immunoprecipitation was 
performed to find out the binding proteins. In the results, 87 kDa complex was 
confirmed by the BN-PAGE and 35 and 40 kDa proteins were identified by 
immunoprecipitation. From the band of 35 kDa, the Cdc50 homolog, a non-catalytic 
subunit of lipid flippase, was identified as an EhRab8A binding protein. Indirect 
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immunofluorescence assay showed that endogenous EhCdc50 localized on the surface, 
but overexpression of EhCdc50 impaired its translocation to the plasma membrane 
and caused its accumulation in the ER. According to the previous report in other 
organisms, overexpression and accumulation of Cdc50 in the ER likely inhibited 
surface transport and function of the plasma membrane lipid flippase P4-ATPase. 
Further, overexpression strain of EhCdc50 gained resistance to miltefosine, which is 
consistent with the prediction that EhCdc50 overexpression caused its accumulation 
in the ER and mislocalization of the unidentified lipid flippase. EhRab8A gene 
silenced strain also showed increased resistance to miltefosine, supporting 
EhRab8A-dependent transport of EhCdc50. This is the first report that EhRab8A 
mediates the transport of EhCdc50 and lipid flippase P4-ATPase from the ER to the 
plasma membrane. 
 According to these results, Cdc50-P4ATPase complex, which carries the flip of 
phosphatidylcholines, is transported to the plasma membrane under the EhRab8A 
regulation. In general, proteins translated on the ribosome are taken into the COPII 
vesicles and transported to the Golgi, followed by other organelles. However, I showed 
that EhRab8A is responsible for the independent pathway. Additionally, it was 
determined that EhRab8A is localized on the ER, which is distinct from EhRab11B 
localization, suggesting that there is a EhRab8A-dependent transport machinery 
from the ER to the plasma membrane in E. histolytica. I also demonstrated that 
EhCdc50 is transported from the ER to the plasma membrane under EhRab8A 
regulation. In summary, I clarified the new transport pathway regulated by EhRab8A 
from the ER to the plasma membrane, which specifically transports the surface 
receptor or flippase. It may contribute to the elucidation of one of the diversified 
membrane trafficking mechanisms in E. histolytica. 
4 
 
Chapter 1. General Introduction 
1-1   Membrane trafficking and Rab GTPases in Eukaryotes 
Eukaryote is comprised of a wide variety of organisms; unicellular and multicellular. 
The former includes protozoan parasites such as Plasmodium falciparum, Giardia 
lamblia, Entamoeba histolytica, and a unicellular fungus Saccharomyces cerevisiae. 
The latter includes Homo sapiens and Arabidopsis thaliana [1]. In all eukaryotic 
cells, organelles carry out specialized functions that are ultimately controlled by 
proteins, which must be correctly targeted to the respective organelles. Thus, protein 
transport system, so-called membrane trafficking, is highly essential for the function 
of the cell [2]. 
 Membrane trafficking is ubiquitous and well-conserved in eukaryotic cells. Small 
GTPases are main regulators, which are also conserved in all eukaryotes, in 
membrane trafficking [2,3]. In general, proteins newly translated by ribosomes in the 
rough endoplasmic reticulum (ER) or the cytoplasm enter into the ER lumen. After 
the proteins are modified by glycosylation or cleavage of the signal peptide, the 
proteins are packed into vesicles and then transported to the Golgi apparatus [4]. In 
this step, Sar1 family of small GTPases regulates vesicle formation. Sar1 GTPase 
takes part in the generation of COPII vesicles on the ER membrane, and then COPII 
vesicles, released from the ER, are uncoated and then fused to the Golgi apparatus [5]. 
At the trans-Golgi network (TGN), the cargo proteins are further packed into 
clathrin-coated vesicles by the regulation of the Arf family of small GTPases [6]. 
Finally, the cargo proteins included in the clathrin-coated vesicles are transported to 
the endosomes, lysosomes, or plasma membrane, where membrane fusion is regulated 
by Rab GTPase family [2]. These Small GTPases, Sar1, Arf and Rab GTPases, 
regulate membrane trafficking as molecular switches, undergoing recycling of 
GTP-bound active form and GDP-bound inactive form. These GTPases are activated 
and inactivated by guanine nucleotide exchange factor (GEF) and GTPase-activating 
protein (GAP), respectively. GEF stimulates the release of guanosine diphosphate 
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(GDP) to allow binding of guanosine triphosphate (GTP). On the other hand, GAP 
stimulates the intrinsic GTPase activity of small GTPases and then converts GTP 
form to GDP form [7].  
 The function of Rab GTPases in vesicle trafficking differs with each isotype. In 
general, Rab GTPases are involved in vesicle tethering and membrane fusion together 
with their effector proteins [3]. Rab GTPases mediate vesicle tethering by recruiting 
tethering factors and SNARE proteins, which stimulates membrane fusion between 
donor and acceptor membranes. After membrane fusion, the GTP hydrolysis of Rab 
GTPase occurs, followed by the conversion of Rab GTPase to its inactive GDP-bound 
form, which resides in the cytoplasm [6,8]. In addition to membrane fusion, other Rab 
isotypes mediate vesicle transport along the cytoskeleton [10,11], such as actin 
filaments and microtubules, together with motor proteins. Rab GTPases also regulate 
the sorting of receptors together with adaptor proteins into the clathrin-coated 
vesicles from the plasma membrane during the initiation/start of endocytosis [6, 9]. 
 Multicellular eukaryotes generally possess a large repertoire of Rab isotypes rather 
than that of unicellular eukaryotes [12]. For instance, H. sapiens and A. thaliana 
encode 60 and 29 Rab genes in their genome, respectively. Meanwhile, S. cerevisiae, G. 
lamblia, and P. falciparum possess 11, 8, and 11 Rab genes, respectively [13]. In 
contrast, the protozoan parasite E. histolytica has 102 Rab genes [14,15], suggesting 
that membrane trafficking in E. histolytica has a dynamic and specific role in 
membrane dynamics, which may be caused by the evolution of Rab GTPases. 
 
1-2  Specific organelles involved in membrane trafficking in E. histolytica  
 E. histolytica is a protozoan parasite belonging to the large taxonomic group 
Amoebozoa, and is the causative agent of amebiasis in humans, accounting for an 
estimated 100,000 annual deaths according to the report from the World Health 
Organization (WHO, 1997). E. histolytica displays two distinct life stages: the 
dormant cyst and proliferative trophozoite stages. Infection is established by oral 
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ingestion of cysts. Cysts are differentiated to trophozoites (excystation) in the small 
intestinal lumen. Trophozoites colonize host intestinal tissues via the galactose and 
N-acetyl-D-galactosamine (Gal/GalNAc)–specific lectin [16,17]. To survive in the 
anaerobic environment within the colon, E. histolytica has adapted their organelles 
and its functions. 
 The absence of many typical organelles found in other eukaryotic cells such as the 
mitochondria, the stacked Golgi apparatus, rough ER, and a microtubule cytoskeleton 
has been reported in E. histolytica [18]. However, it is postulated that this parasite 
carries out functions such as post-translational modifications and protein targeting to 
subcellular compartments that are performed by the Golgi apparatus in usual 
eukaryotes. It is suggested that those functions take place in Golgi-like structures. In 
the case of mitochondria, E. histolytica possesses highly degenerate 
mitochondrion-related organelles (MROs) called mitosomes, which lack many 
features associated with canonical aerobic mitochondria [19]. E. histolytica mitosomes 
have minimal and mostly divergent transport systems such as protein import systems 
that lack a canonical targeting signal. According to these reports, the protein 
transport machinery might be diversified in E. histolytica. 
 
1-3   The Rab GTPases in E. histolytica  
  Trophozoites of E. histolytica engulf human intestinal tissue cells and bacteria in 
the large intestine by phagocytosis. Phagocytosis is a ubiquitous mechanism that is 
evolutionarily conserved in a wide range of eukaryotes, and comprises several key 
steps: receptor-mediated recognition of the particle (prey), signal transduction, 
rearrangement of the cytoskeleton, and remodeling of the membrane and contents 
[20,21]. The surface receptor for a variety of targets activates a number of signaling 
cascades leading to target-dependent responses [22]. The subsequent maturation of 
phagosomes requires interactions between the phagosomes and various intracellular 
compartments, such as endosomes, lysosomes, the ER, and the Golgi apparatus 
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[23-25]. Membrane trafficking during phagocytosis, like receptor transport to the cell 
surface and membrane fusion between phagosomes and other intracellular 
compartments, is regulated by specific Rab GTPases localized to each organelle.  
 Previously, EhRabB, EhRab5, EhRab7A, and EhRab7B have been shown to be 
sequentially involved in phagocytosis in E. histolytica. First, EhRabB is recruited, 
along with phosphatidylinositol-3-phosphate, to the phagocytic cup. Simultaneously, a 
unique compartment called prephagosomal vacuole (PPV) is formed by the sequential 
action involving EhRab5 and EhRab7A. Finally, EhRab7A-positive PPVs and 
EhRab7B-positive lysosomes/late endosomes fuse with the phagosome to allow its full 
maturation [26-29]. Besides the above-mentioned EhRab proteins, localization and/or 
functions of only 6 amebic Rab proteins have been previously shown. It has been 
reported that EhRab11A is involved in encystation [30], whereas EhRab11B is 
involved in the transport and secretion of cysteine protease [31]. It was also shown 
that EhRabA and EhRab8A are localized to the leading edge of the cell and the 
plasma membrane, respectively [32-34].  
 To reveal the pathway regulated by respective Rab GTPase, it is necessary to find 
their corresponding effector proteins. However, effectors and binding proteins have 
not been identified for the previously reported EhRab proteins except for EhRab7A. 
Binding of the retromer complex, more specifically one of its components Vps26 [27], 
to Rab7 was first reported in E. histolytica, and subsequently observed in mammalian 
cells, indicating that Rab7 is involved in cargo recognition and sorting in the 
endosome of a wide range of eukaryotes. 
 It is supposed that Rab GTPases and their effector proteins have diverse functions 
compared with other eukaryotes. However, the roles of other Rab GTPases have not 
been elucidated. The realization of their unveiled function will contribute to the 
understanding of membrane trafficking not only in E. histolytica but also in other 
eukaryotes. 
8 
 
Chapter 2. The membrane trafficking pathway regulated by EhRab8A 
2-1 Abstract 
 In E. histolytica Rab8A was reported to be involved in the transport regulation of a 
surface receptor, which is important for the target recognition in phagocytosis. Here, I 
showed that EhRab8A, which generally regulates the trafficking from the trans-Golgi 
network to the plasma membrane in other organisms, primarily resides in the ER and 
participates in phagocytosis. Overexpression of wild-type EhRab8A augmented 
phagocytosis whereas expression of the dominant-negative form of EhRab8A resulted 
in reduced phagocytosis. Further, EhRab8A was localized on the ER membrane, close 
to an ER-residing chaperon protein, EhBiP, but the different compartment from 
EhSec13, which is one of a component of the COPII vesicle. These results indicated 
that EhRab8A regulates transport of surface receptor(s) for the prey from the ER to 
the plasma membrane by the COPII-independent pathway. To the best of my 
knowledge, this is the first study to show that the ER-resident Rab8A is involved in 
phagocytosis through the transport of plasma membrane proteins. 
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2-2 Introduction 
 In the previous report, in order to clarify molecules and mechanisms involved in 
phagocytosis of E. histolytica, the proteomic analysis was performed to identify 
proteins associated with the phagosomes. 14 Rab GTPases, among 85 total proteins, 
were identified by liquid chromatography and mass spectrometry from the isolated 
phagosomes of E. histolytica [35-37]. Eh Rab8A, among 14 Rab GTPases from the 
phagosome proteomic analysis, was examined for the following analysis. 
Down-regulation of EhRab8A by small antisense RNA-mediated transcriptional gene 
silencing, remarkably reduced adherence and phagocytosis of erythrocytes, bacteria, 
and carboxylated latex beads. Surface biotinylation followed by SDS-PAGE analysis 
revealed that the surface expression of several proteins presumably involved in target 
recognition was reduced in the EhRab8A gene silenced strain. According to these 
reports, EhRab8A is involved in phagocytosis through the regulation of trafficking of a 
surface receptor to the plasma membrane. 
 Generally, in the eukaryotes secretory pathway, Rab11 functions upstream of Rab8. 
The GTP-bound active form of Rab11 binds its effector molecule, Rabin8, which is a 
GEF of Rab8 [38]. Consistently, partial colocalization of Rab8 and Rab11 in the TGN 
has been reported in mammalian cells [39,40]. This Rab cascade, comprising Ypt32p 
and Sec2p, homologues of Rab11 and Rabin8, respectively, is also conserved in the 
budding yeast [41]. In E. histolytica, it has previously reported that overexpression of 
EhRab11B resulted in massive mis-secretion of cysteine proteases, suggesting that 
EhRab11B is the primary regulator of cysteine protease transport from the TGN to 
the plasma membrane in E. histolytica [31]. On the other hand, the transport 
pathway regulated by EhRab8A was unveiled in E. histolytica.  
 
2-3 Materials and Methods 
2-3-1 Culture 
Trophozoites of the E. histolytica strain HM-1: IMSS cl-6 were cultured axenically at 
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35°C in 13 × 100 mm screw-capped Pyrex glass tubes or plastic culture flasks in 
BI-S-33 medium, as previously described [42,43]. 
 
2-3-2 Construction and establishment of a myc-tagged EhRab8-expressing 
strain, and strains expressing dominant-active and -negative EhRab8A 
mutants  
A plasmid constructed as follows for the creation of a transformant wherein EhRab8A 
with myc-tagged at the amino terminus, was expressed. A 600-bp DNA fragment 
containing the EhRab8A-coding sequence was amplified by PCR from cDNA with the 
following oligonucleotides: 5' -TCA GAA GAG GAT CTT ATG TCG GAG AAG GAT 
TCA ACA-3' and 5' -GTT CAA CTC GAG TTA ACA TCC AGT TGA TTC AGT-3' (the 
XhoI restriction sites are underlined). The amplified fragment was cloned into 
XhoI-digested pKT-3M [26] with an Infusion cloning kit (Clontech). Plasmids that 
expressed EhRab8A S21N (GDP-bound dominant-negative) and Q66L (GTP-bound 
dominant-active) mutants were constructed by PCR-mediated mutagenesis [44] using 
a PrimeSTAR Mutagenesis Basal Kit (Takara). The EhRab8A myc-tagged 
EhRab8-expressing strain, and strains expressing dominant-active and -negative 
EhRab8A mutants were established by transfection of the HM-1: IMSS cl-6 strain by 
liposome-mediated transfection, as previously described [26]; stable transformants 
were cultured in the medium containing 10 µg/ml Geneticin (Life Tech Oriental). 
Moreover, I established a control mock transformant by transfection of the HM-1: 
IMSS cl-6 strain with pKT-3M. 
 
2-3-3 Production of recombinant EhRab8A 
In order to generate a plasmid expressing the maltose-binding protein (MBP)-fused 
EhRab8A-recombinant protein, the full-length EhRab8A open reading frame (ORF) 
was inserted into the pMAL-c2X vector (New England Biolabs, Ipswich, MA, USA). 
Recombinant protein was expressed using the E. coli strain BL21 (DE3) and purified 
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according to the manufacturer’s instructions. 
 
2-3-4 Antibodies  
Antiserum was commercially raised against recombinant EhRab8A, EhBiP, EhSec13, 
or EhRab11B in rabbits (Eurofins Genomics, Japan). The EhRab8A IgG was further 
purified with HiTrap NHS-activated HP column (Amersham) coupled with purified 
recombinant MBP-conjugated-EhRab8A according to the manufacturer’s instruction. 
The antiserum was purified using a HiTrap protein G kit (GE Healthcare).  
 
2-3-5 Phagocytosis assay  
Phagocytosis was assayed by microscopy. The myc-EhRab8A dominant-negative 
mutant-expressing cells were attached to slide glass and engulfed with 
PKH26-labeled (Sigma) erythrocytes for 20 min. The samples were fixed, stained with 
an anti-myc antibody, and visualized with an anti-mouse Alexa 488 antibody, as 
described in the following indirect immunofluorescence assay. The fluorescent 
intensity of the PKH26 signal in the trophozoites stained with the anti-myc antibody 
was captured on a Carl-Zeiss LSM780 confocal laser-scanning microscope, and the 
images were analyzed with ZEN software (Zeiss).  
 
2-3-6 Subcellular fractionation 
The accessibility by proteinase K assay was performed as reported previously with 
some modifications [28]. Approximately 3 x 105 amoeba cells were washed with cold 
PBS containing 2% glucose, resuspended in homogenization buffer (250 mM sucrose, 
50 mM Tris, pH 7.5, 50 mM NaCl, 0.1 mg/ml E-64), and homogenized on ice with 30 
strokes by a Dounce homogenizer with a tight fitting pestle. After unbroken cells were 
removed by centrifugation at 400 x g for 2 min, the supernatant was centrifuged at 
13,000 x g at 4°C for 10 min to obtain the pellet (p13) and supernatant (s13) fractions. 
The s13 fraction was further separated by centrifugation at 100,000 x g at 4°C for 1 h 
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to obtain soluble (s100) fractions. These fractions were subjected to immunoblot 
analyses with anti-EhRab8A, anti-CPBF1 [45], or anti-ICP1 antibodies [46]. 
 
2-3-7 Indirect immunofluorescence assay 
An indirect immunofluorescence assay was conducted, essentially as previously 
described [26]. Trophozoites were transferred to 8-mm round Ills on a slide glass, fixed, 
permeabilized, and reacted with an anti-myc 9E10 monoclonal antibody (Santa Cruz 
Biotech) to detect myc-tagged EhRab8A wild-type and myc-tagged EhRab8A-GDP and 
GTP mutants, anti-EhRab11B (this study), anti-EhVps26 [27], anti-EhBiP (this 
study), anti-EhSec13 (this study) polyclonal rabbit sera.  
 
2-4 Results 
2-4-1 Establishment of a myc-tagged EhRab8-expressing strain 
 The transformant cells expressing EhRab8A with the amino-terminal myc-tag were 
established and subjected to immunoblots using anti-EhRab8A and anti-myc 
antibodies (Fig. 1A). Two bands were observed in the mock control using 
anti-EhRab8A antibody; the top (23.8 kDa, red asterisk) and bottom (22.8 kDa, black 
asterisk) bands likely corresponded to modified and non-modified endogenous 
EhRab8A. In myc-EhRab8A-expressing cells, four bands were observed; the two top 
bands (27.2 kDa; red cross, and 26.4; black cross) corresponded to the exogenously 
expressed myc-tagged EhRab8A with or without modification(s) whereas the bottom 
two bands correspond to the endogenous EhRab8A. The nature of the modification 
remains unknown. I examined the nature (membrane-bound or soluble) of two forms 
of EhRab8A by differential centrifugation. The 22.8- and 26.4-kDa bands were 
recovered in the pellet fraction after centrifugation at 13,000 × g together with a 
transmembrane protein CPBF1 [45], while the 23.8- and 27.2-kDa bands were found 
in the soluble fraction of centrifugation at 100,000 × g, together with a cytosolic 
soluble protein ICP1 [46] (Fig. 1B). The amount of exogenously expressed 
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myc-EhRab8A protein was 2.1 ± 0.64-fold higher than that of the endogenous protein 
(Fig. 1A). 
 
2-4-2 Overexpression of wild-type Rab8A enhanced phagocytosis whereas 
a dominant-negative Rab8A mutant inhibited phagocytosis  
 The previous proteomic study of isolated phagosomes has revealed that 14 amebic 
Rab proteins are localized to phagosomes [35,36]. EhRab8A was analyzed as an 
important factor for the phagocytosis, and it was involved in the trafficking of 
proteins to the ER. To confirm if Rab8A functions for the phagocytosis by regulating 
the surface proteins, I established Rab8A overexpressed strain and 
dominant-negative/active strain and examine the phagocytosis efficient. 
 Nucleotide-fixed state mutations can be engineered to alter the activity of Rab 
proteins [2]. Two mutants of myc-EhRab8A, a GTP-fixed Q66L mutant and a 
GDP-fixed S21N mutant, were generated and introduced into the ameba trophozoites. 
One of the two mutants, in which Gln in the second GTP-binding motif was replaced 
with Leu, was designed to have reduced GTPase activity and regarded as a 
constitutively active (GTP-fixed) mutant (Q66L) [2,47]. The other mutant possessing 
a Ser-to-Asn mutation in the first GTP binding motif is assumed to possess a lower 
affinity for GTP than for GDP and function as a constitutively negative (GDP-fixed) 
form (S21N) [48]. I quantified the amount of fluorescein-labeled erythrocytes ingested 
by the trophozoites expressing either wild-type myc-EhRab8A or two mutant forms of 
myc-EhRab8A (Fig. 2A and B). The intensity of fluorescence reflected the amount of 
ingested erythrocytes significantly increased in wild-type myc-EhRab8A-expressing 
cells compared to the mock control (160% ± 17%; p < 0.02, Fig. 2B). In contrast, 
expression of the GTP-fixed mutant had a negative effect on erythrophagocytosis 
(68% ± 4.3% compared to the control; p < 0.01). Furthermore, the GTP-fixed mutant 
transformant exhibited growth retardation compared with mock control, the 
transformants expressing wild-type EhRab8A or GDP-fixed mutant (Fig. 2C) (mock; 
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18.3 ± 1.03 hr, wild-type EhRab8A, 17.8 ± 0.95 hr; GDP-fixed mutant, 17.6 ± 1.06 hr; 
GTP-fixed mutant; 22.4 ± 0.71 hr, p < 0.03 between GTP-fixed mutant and each of 
mock, GDP-fixed mutant transformant, or wild-type). Neither positive nor negative 
effect of the GDP-fixed mutation on erythrophagocytosis was observed. 
 
2-4-3 EhRab8A localized to the ER, but neither to the trans-Golgi network 
nor lysosomes 
 EhRab8A is homologous to yeast Sec4p and human Rab8, with 49%–53% amino acid 
identity [14,32] (Fig. 3). Yeast Sec4p and human Rab8 are known to be involved in 
trafficking from the trans-Golgi network (TGN) to the PM [8,49]. Further, 
colocalization of Rab8 with Rab11, which is the upstream regulator of Rab8, has also 
been reported [50,51]. Thus, I examined whether EhRab8A was colocalized with 
EhRab11B, which was previously demonstrated to be on the TGN [31]. An indirect 
immunofluorescence assay of the myc-EhRab8A cells conducted using anti-EhRab8A 
and anti-myc antibodies revealed high colocalization (Pearson’s correlation 
coefficient: R = 0.83) (Fig. 4A), indicating that endogenous EhRab8A and exogenously 
expressed myc-EhRab8A were localized to the same organelle(s)/compartments. 
EhRab8A did not colocalize with EhRab11B, which was visualized with an 
anti-EhRab11B antibody [31] (R = 0.24, Fig. 4B). Furthermore, EhRab8A did not 
colocalize with EhVps26, one of the retromer component that is involved in the 
recycling of receptors in the TGN and the endosomal compartment and well 
colocalized with the late endosomal marker EhRab7A [27,52,53] (R = 0.05, Fig. 5A). 
Localization of EhRab8A also clearly differed from that of EhRab7B, which is 
localized to lysosomes [28] (Fig. 5B). This observation was in contrast to other 
organisms [40,51]. 
 Next, to find out the organelle compartment where EhRab8A is localized on, I 
accomplished the Percoll fractionation. It is possible to separate organelle 
compartments physically by two rounds of discontinuous Percoll gradient 
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ultracentrifugation[19], followed by immunoblot assay, in which the distribution 
pattern of EhRab8A was similar to that of Sec13 (EHI_001050, 38% amino-acid 
identity to human Sec13, E-value = 6e-46) [5], a component of the COPII vesicle (Fig. 
6). Differently from this observation, EhRab8A was fractionated in a distinct fraction 
from Cpn60, the chaperonin family protein on the mitosome. It suggests that 
EhRab8A is localized on the ER. In mammals, Rab10, which shares 70% amino acid 
identity to Rab8 [13,54] (Fig. 3), is known to localize to endosomes (e.g., in 
Madin–Darby canine kidney epithelial cells) [55,56]. In addition, Rab10 is localized to 
the ER in Xenopus laevis egg, COS-7, and HeLa cells [57], which is consistent the 
result that EhRab8A localizes to the ER.  
 I next confirmed EhRab8A localization using antibodies raised against bacterial 
recombinant proteins of EhSec13 and the ER luminal chaperone EhBiP (EHI_199890, 
64% amino acid identity to human BiP, E-value = 0) [58]. A subdomain of the ER, 
where COPII vesicle budding occurs, was named the ER exit site (ERES) [59], and it 
was visualized with the anti-EhSec13 antibody. EhSec13 did not colocalize with 
EhRab8A (R = 0.15, Fig. 7A). Next, an indirect immunofluorescence assay performed 
using the anti-EhBiP antibody revealed partial colocalization of myc-EhRab8A and 
EhBiP, suggesting that EhRab8A was localized to the ER or a compartment adjacent 
to the ER (R = 0.7, Fig. 7B).  
 Confocal fluorescence micrographs revealed that the localization of myc-EhRab8A 
Q66L mutant was similar to that of wild-type EhRab8A, and also well colocalized to 
EhBiP, whereas S21N mutant revealed dispersed cytosolic staining like the Rab8 SN 
mutant in other organisms [60,61] (Fig. 8). The localization of Q66L and S21N 
mutants is consistent with presumed characteristics of GTP- and GDP-fixed mutants. 
Expression of GTP- or GDP-fixed mutants did not affect the ER morphology, which is 
visualized with anti-BiP antibody.  
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2-5 Discussion  
2-5-1 ER-localized EhRab8A is required for phagocytosis 
 In this study, I have shown using two genetic approaches that in E. histolyitca 
unique ER-localized EhRab8 is involved in phagocytosis. I have shown that 
overexpression of the wild-type or GTP-fixed mutant of EhRab8A enhanced or 
reduced phagocytosis, respectively (Fig. 2). Rab8 is a member of the highly conserved 
Rab subfamily in eukaryotes, including Metazoa (Caenorhabditis elegans, 
Nematostella vectensis), Choanozoa (Monosiga brevicollis), Fungi (Saccharomyces 
cerevisiae), Amoebozoa (Dictyostelium discoideum), Viridiplantae (Arabidopsis 
thaliana), Stramenopiles (Phytophthora sojae), Ciliophora (Tetrahymena 
thermophila), and Chizopyrenida (Naegleria gruberi), but missing in Diplomonadida 
(Giardia lamblia) and Trichomonadida (Trichomonas vaginalis) [13,15,62]. In 
mammals and yeasts, Rab8 is involved in trafficking from the TGN to the PM [3]. In 
free-living D. discoideum, Rab8 is localized to a contractile vacuole, which is a 
specialized osmoregulatory organelle involved in water expulsion [63]. A line of 
evidence provided in this study suggests that EhRab8A plays a unique function in 
Entamoeba: EhRab8A is involved in the ameba’s adherence to prey by mediating the 
transport of candidate receptor(s) to the plasma membrane. Until now, many ER 
proteins including Rab1 have been identified in proteome analyses of macrophage 
phagosomes [23,25]; the results suggested that the ER may supply membranes to the 
plasma membrane to engulf large foreign particles and to recruit MHC class I 
molecules to phagosomes [64,65]. Although it remains to be debated whether the ER 
is involved in phagocytosis, more specifically the ER provides membrane to 
newly-formed phagocytosis in E. histolytica, several ER proteins were identified from 
purified phagosomes by previous proteomic analyses in E. histolytica: calreticulin, 
BiP [66], and COPII components [67]. These data are consistent with the notion that 
the amoebic ER is involved in progression of phagocytosis. It has been previously 
shown that an ER luminal protein, calreticulin, is present on the amoebic cell surface 
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and involved in erythrophagocytosis, suggesting that the ER and the plasma 
membrane is dynamically interconnected in E. histolytica [68,69].  
 
2-5-2 Lack of the Rab11-Rab8 cascade for transport from the TGN to the 
PM in E. histolytica  
 In the mammalian cells, Rab8 functions with Rab11 and Rabin8, which is a GEF of 
Rab8, as a Rab11-Rabin8-Rab8 cascade [3]. In contrast, in E. histolytica, EhRab8A 
and EhRab11B were not colocalized (Fig. 4), indicating that EhRab8A and EhRab11B 
regulate non-overlapping steps of the same pathway or independent pathways. It was 
reported that EhRab11B regulates cysteine protease transport from the TGN to the 
plasma membrane in E. histolytica [31]. These data suggest that the role and its 
regulation of Rab8 in Entamoeba are highly divergent from that in Opisthokonts. 
Identification and characterization of effector proteins (and upstream GEF) of 
EhRab8A, which is underway, may help elucidate the evolution of Rab8-mediated 
membrane trafficking in divergent eukaryotes.  
 
2-5-3 EhRab8A may be involved in a non-conventional traffic pathway 
from the ER to the plasma membrane 
 The absence of EhRab8A at the ERES (Fig. 7) was noteworthy. In general, cargo 
proteins transported to the Golgi are recognized by p24 families of proteins and a 
component of COPII, Sec24 protein, and then packed into the COPII vesicles in the 
ERES [70,71]. During formation of the COPII vesicle, a member of the Arf family of 
GTPases called Sar1, together with the p24 families of proteins, plays a pivotal role in 
cargo sorting into COPII vesicles in the ER [72]. Thus, my data suggested that the 
cargo sorting in a pathway regulated by EhRab8A differed from the canonical 
mechanism for the COPII vesicle formation mediated by the p24 family and Sec24. 
 Human Rab10 is closely related to Rab8 and localized to the ER (70% amino acid 
identity, Fig. 3), and forms a specialized domain linked to phospholipid synthesis 
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involving phosphatidylinositol synthase (PIS) and ethanolamine phosphotransferase 
1 (CEPT1) [57]. It has also been shown that expression of a mutant Rab10 or 
depletion of endogenous Rab10 reduces ER tubular extension, likely attributable to a 
disturbance of the Rab10-associated enzymes involved in phospholipid biosynthesis in 
the ER subdomain [57]. The E. histolytica genome encodes both PIS and CEPT 
(EHI_069630 for CDP-DAG inositol 3-phosphatidyltransferase; EHI_148580 and 
EHI_152340 for ethanolamine/choline kinase). Thus, it is plausible that EhRab8A 
regulates the transport of plasma membrane proteins via the lipid biosynthesis. My 
preliminary co-immunoprecipitation of EhRab8A identified several lipid metabolizing 
enzymes, which also supports a premise that EhRab8A is involved in 
lipid/phospholipid biosynthesis and transfer.  
 
2-6 Figure Legends  
Fig. 1. Subcellular fractionation of EhRab8A  
A. Immunoblot analysis of endogenous (wild-type) and myc-EhRab8A detected by 
anti-EhRab8A (left) and anti-myc (right) antibodies. In mock cells, two bands 
corresponding to endogenous unmodified (a black asterisk) and modified EhRab8A (a 
red asterisk) were detected. In myc-EhRab8A transformant cells, unmodified (black 
crosses) and modified myc-tagged EhRab8A (red crosses) were detected. B. 
Immunoblot analysis of EhRab8A in fractionated cell lysates. Lysates from 
myc-EhRab8A transformant cells were fractionated by centrifugation into the 
low-speed pellet (p13, the pellet fraction of 13,000 x g centrifugation), the high-speed 
pellet (p100, the pellet fraction of 100,000 x g centrifugation), and the supernatant 
fractions (s100, the supernatant fraction of 100,000 x g centrifugation). These 
fractions were subjected to immunoblot analysis using anti-EhRab8A, anti-CPBF1 (a 
membrane protein), and anti-ICP1 (a cytosolic protein) antibodies. Note that two 
bands corresponding to endogenous unmodified (a black asterisk) and myc-tagged 
unmodified EhRab8A (a black cross) were fractionated to the membrane fractions 
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(p13 and p100), and the other two bands corresponding to endogenous modified (a red 
asterisk) and myc-tagged modified EhRab8A (a red cross) were partitioned to the 
cytosolic fraction (s100). 
 
Fig. 2. Expression of EhRab8A GTP-bound mutant caused a defect in 
phagocytosis.  
A. Immunofluorescence imaging of EhRab8A and erythrophagocytosis. Transformant 
trophozoites expressing myc-EhRab8A wild-type or myc-EhRab8A-Q66L mutant, and 
mock transformant cells were mixed with PKH-labeled erythrocytes for 20 min at 
37°C and reacted with an anti-myc antibody in an immunofluorescence assay. B. 
Efficiency of erythrophagocytosis by the transformants expressing myc-EhRab8A 
wild-type, myc-EhRab8A-Q66L, or myc-EhRab8A-S21N mutant, and mock 
transformant. The total fluorescence intensities of the PKH26-labeled erythrocytes 
ingested by a single trophozoite were measured, and the average of the total 
fluorescence intensities per trophozoite for each strain are shown. Note that 
expression of myc-EhRab8A wild-type and the myc-EhRab8A–Q66L mutant enhanced 
and reduced erythrophagocytosis, respectively. C. The population doubling time of 
myc-EhRab8A wild-type, myc-EhRab8A-Q66L, myc-EhRab8A-S21N mutant, and 
mock transformant cells. The correlation coefficients  
 
Fig. 3. Sequence alignment and identity 
A. Sequence alignment of EhRab8A, EhRab11B, Homo sapiens Rab8A, Rab10, and 
Saccharomyces cerevisiae Sec4p. Amino acids sequences were aligned with the 
ClustalW (ver  2.1). The GTP-binding consensus region and switch I and II regions, 
which are involved in the interaction with effectors, are shown in the yellow box and 
red lines, respectively. B. Percentage identity of EhRab8A, EhRab11B, Homo sapiens 
Rab8A, Rab10, and Saccharomyces cerevisiae Sec4p. Amino acid percentage identity 
matrix was created by ClustalW. 
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Fig. 4. Lack of colocalization of exogenously expressed myc-EhRab8A and 
the trans-Golgi network marker 
Immunofluorescence imaging of exogenously expressed myc-EhRab8A, stained with 
anti-myc (green) and endogenous EhRab8A, stained with anti-EhRab8A (A, red), 
anti-EhRab11B antibodies (B, red). Histograms of the green and red intensities along 
the red lines are shown at the bottom left of panels A and B. Major peaks of green, red, 
and merged signals are yellow. The lengths of the lines are also shown. R = Pearson’s 
correlation coefficient. Bars, 5 µm.  
 
Fig. 5. Lack of colocalization of exogenously expressed myc-EhRab8A and 
the endosome and lysosome markers 
Immunofluorescence imaging of exogenously expressed myc-EhRab8A, stained with 
anti-myc (green) and the endosome, stained with anti-EhVps26 antibody (A, red), and 
the lysosome, stained with lysotracker (B, red). Histograms of the green and red 
intensities along the red lines are shown at the bottom left of panels A and B. Major 
peaks of green, red, and lysosome depicted by white arrows. ßThe lengths of the lines 
are also shown. R = Pearson’s correlation coefficient. Bars, 5 µm.  
 
Fig. 6. Percoll gradient fractionation of EhRab8A 
Homogenate prepared from wild-type cells was fractionated by two series of Percoll 
gradient ultracentrifugation according to the previous report [19], and subjected to 
immunoblot using anti-Cpn60 (mitosome), anti-EhRab8A, and anti-Sec13 antibodies, 
respectively. First Percoll fractions which is positive for Cpn60 were subjected to the 
2nd Percoll fractionation. Membrane-bound Sec13 was fractionated to J to L, and 
Cpn60 was detected from the L to N fractions. EhRab8A was co-fractionated with 
Sec13 positive fraction (J and K).  
 
Fig. 7. Colocalization of exogenously expressed myc-EhRab8A and 
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endoplasmic reticulum markers 
Immunofluorescence imaging of exogenously expressed myc-EhRab8A, stained with 
anti-myc (green), and the anti-EhSec13 (A, red) or anti-EhBiP (B, red) antibodies. 
Histograms of the green and red intensities along the lines indicated in the islets on 
the right bottom of each image are shown at the bottom left of panels A–B. Major 
peaks of green, red, and merged signals are depicted by arrows. The lengths of the 
lines are also shown. In the bottom right of panels A–B, scatter plots showing the 
results of the colocalization analyses are shown. R = Pearson's correlation coefficient. 
Bars, 5 µm.  
 
Fig. 8. Subcellular localization of myc-EhRab8A wild-type and mutants.  
The GTP-bound Q66L or GDP-bound S21N mutants were expressed under the 
regulation of the constitutive cysteine synthase promoter. Exogenous myc-EhRab8A 
was stained with the anti-myc 9E10 antibody. GTP-bound myc-EhRab8A Q66L was 
localized to the endoplasmic reticulum stained with the anti-BiP antibody, and the 
patter was similar to that of the wild-type myc-EhRab8A. GDP-bound myc-EhRab8A 
S21N showed cytosolic staining. 
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Chapter 3. Identification of EhCdc50 as binding protein of EhRab8A 
3-1 Abstract 
 Membrane traffic plays a pivotal role in virulence in the enteric protozoan parasite 
Entamoeba histolytica. EhRab8A small GTPase is a key regulator of membrane 
traffic at the endoplasmic reticulum (ER) of this protist and is involved in the 
transport of plasma membrane proteins. Here I identified the binding proteins of 
EhRab8A. The Cdc50 homolog, a non-catalytic subunit of lipid flippase, was identified 
as an EhRab8A binding protein candidate by affinity coimmunoprecipitation. Binding 
of EhRab8A to EhCdc50 was also confirmed by reciprocal immunoprecipitation and 
blue-native polyacrylamide gel electrophoresis, the latter of which revealed an 87 kDa 
complex. Indirect immunofluorescence imaging with and without Triton X100 showed 
that endogenous EhCdc50 localized on the surface in the absence of permeabilizing 
agent but was observed on the intracellular structures and overlapped with the ER 
marker Bip when Triton X100 was used. Overexpression of N-terminal HA-tagged 
EhCdc50 impaired its translocation to the plasma membrane and caused its 
accumulation in the ER. As reported previously in other organisms, overexpression 
and accumulation of Cdc50 in the ER likely inhibited surface transport and function 
of the plasma membrane lipid flippase P4-ATPase. Interestingly, 
HA-EhCdc50-expressing trophozoites gained resistance to miltefosine, which is 
consistent with the prediction that HA-EhCdc50 overexpression caused its 
accumulation in the ER and mislocalization of the unidentified lipid flippase. 
Similarly, EhRab8A gene silenced trophozoites showed increased resistance to 
miltefosine, supporting EhRab8A-dependent transport of EhCdc50. This study 
demonstrated for the first time that EhRab8A mediates the transport of EhCdc50 and 
lipid flippase P4-ATPase from the ER to the plasma membrane. 
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3-2 Introduction 
 Identification of binding proteins of Rab GTPases often provides necessary clues to 
the mechanisms of trafficking pathways [73]. A plethora of binding proteins and 
effectors for most Rab GTPases have been studied to elucidate the molecular 
mechanism of the Rab-mediated trafficking in human and major model organisms [3]. 
For example, Rab11 and Rab8 coordinately control trafficking from the trans-Golgi to 
the plasma membrane in mammalian cells together with their effector proteins, 
Rab11-family interacting proteins (FIPs) and Rabin8 (Rab8-guanine nucleotide 
exchange factor). Neurite outgrowth requires a cascade of Rab11, Rabin8 and Rab8 
activities in the recycling endosomes [74]. In ciliary membrane trafficking, Rab11 and 
Rab8 sort rhodopsin at the trans-Golgi membrane and transport rhodopsin to the 
periciliary membrane of photoreceptor cells followed by the Golgi recruitment of FIP3 
and Rabin8 [75]. In the social amoeba Dictyostelium discoideum, intracellular 
osmoregulation is controlled by contractile vacuole fusion with the plasma membrane 
under hypotonic conditions; and this process is regulated by the serial recruitment of 
Rab11, Rab11 effector, Rab8 and Rab8-GTPase activating protein on the contractile 
vacuole membrane [76].  Thus, the Rab11 and Rab8 cascade, which is mediated by 
Rab8 effector proteins, is conserved in many tissues and organisms. Other effector 
protein is also reported in yeast Rab8 homolog, Sec4p. GTP-bound active form of 
Sec4p interacts with Sro7, a member of the structurally conserved tomosyn/Sro7 
family. Sro7 functions as a Sec4 effector that helps to tether post-Golgi vesicles to the 
plasma membrane together with SNARE complex, followed by membrane fusion [77]. 
Transport pathway of EhRab8A was identified, however its function or cargo proteins 
have not been clarified. It is crucial to find out the binding protein of EhRab8A to 
elucidate the function. 
 Cdc50, which is a non-catalytic subunit and form heteromeric complexes with 
P4ATPase, is conserved protein in eukaryotes. Members of the P4 subfamily of P-type 
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ATPases catalyze phospholipid transport and create membrane lipid asymmetry [78]. 
The Cdc50-P4ATPase complex is transported from the ER to the TGN, then delivered 
to the late secretory and endocytic compartments, and the plasma membrane. 
According to the previous report in eukaryotes, the trafficking pathway of the 
Cdc50-P4ATPase complex is COPII dependent as well as other proteins, and there is 
no report that Cdc50 and P4ATPase interact with Rab GTPases directly. 
 
3-3 Materials and Methods 
3-3-1 Antibodies 
The anti-EhBip, anti-EhRab8A, anti-EhVps26 [27] antibodies used were described 
previously. The anti-HA antibody clone 16B12 and anti-Myc clone 9E10 monoclonal 
antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). 
Anti-EhCdc50 antibody was produced as described below. 
 
3-3-2 Creation of E. histolytica  transformant lines 
A plasmid expressing N-terminal 3HA-tagged EhCdc50 (HA-EhCdc50) was 
constructed as follows. A 966-base pair DNA fragment containing the 
EhCDC50-coding sequence was amplified by PCR from E. histolytica genomic DNA 
using the following oligonucleotides: 
5′-CCCGGGATGTCAGAGAAAGTAAAGGGACTTG-3′ and 
5′-CTCGAGTTACCATCGAAGAAATCTC-3′ (the SmaI and XhoI restriction sites are 
underlined). The amplified fragment was cloned into pCR™-Blunt II-TOPO™ with a 
Zero Blunt™ TOPO™ PCR Cloning Kit (Invitrogen, Carlsbad, CA, USA). This 
plasmid was digested with SmaI and XhoI and the insert was cloned into SmaI- and 
XhoI-digested pKT-3HA. The plasmid was introduced into trophozoites as described 
previously [79]. Construction of the 3Myc-EhRab8A (Myc-EhRab8A)-expressing line 
from HM-1 and EhRab8A gene-silenced line from G3 strain were described in 
chapter2. 
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3-3-3 Blue-Native Polyacrylamide gel Electrophoresis (BN-PAGE) 
Approximately 1 × 106 cells were harvested at the late logarithmic growth phase, 
washed with cold phosphate-buffered saline (PBS) and homogenized in 0.5 mL 
homogenization buffer (250 mM sucrose, 50 mM Tris-HCl, 50 mM NaCl, 5 mM MgCl2, 
1 mM E-64, pH 7.5) with 30 strokes of a Dounce homogenizer. Samples were 
centrifuged at 13,000 g at 4 °C for 10 min to obtain the pellet fraction (p13). The p13 
fraction was solubilized in homogenization buffer containing 2% digitonin at 4 °C for 
30 min. Solubilized samples were collected by centrifugation (13,000 g, 4°C, 10 min) 
and subjected to BN-PAGE using the NativePAGETM NovexH Bis-Tris Gel System 
(Invitrogen) according to the manufacturer’s protocol. The resolved proteins were 
transferred to a polyvinylidene fluoride membrane and the Myc-EhRab8A protein 
complex was detected using anti-Myc antibody. 
 
3-3-4 Coimmunoprecipitation 
Approximately 4 × 106 Myc-EhRab8A-expressing or mock control trophozoites were 
harvested in the logarithmic growth phase, washed with 2% glucose/PBS and 
resuspended in 1 mL of PBS. The cell suspension was incubated with 2 mM 
3,3′-dithiodipropionic acid di(N-hydroxysuccinimide ester) (DSP) (Sigma-Aldrich, St. 
Louis, MO, USA) for cross-linking for 30 min at room temperature according to the 
manufacturer’s protocol. The samples were mixed with 1 mL homogenization buffer 
(250 mM sucrose, 50 mM Tris-HCl, 50 mM NaCl, 5 mM MgCl2, 1 mM E-64, pH 7.5) 
and homogenized on ice with 30 strokes of a Dounce homogenizer. After unbroken 
cells were removed by centrifugation at 400 g for 2 min, the supernatant was 
centrifuged to obtain the p13 fraction which was primarily enriched with EhRab8A. 
The p13 fraction was resuspended in approximately 0.5 mL of homogenization buffer 
containing 2% digitonin at a 2 mg/mL protein concentration and then incubated with 
Protein G Sepharose (Sigma-Aldrich) at 4 °C for 60 min to reduce non-specific binding 
during coimmunoprecipitation. The Myc-EhRab8A protein complex was 
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immunoprecipitated with anti-Myc-antibody-conjugated agarose (Sigma-Aldrich) at 
4 °C for 3 h and then washed with homogenization buffer containing 0.5% digitonin. 
The Myc-EhRab8A protein complex was eluted with homogenization buffer containing 
2% digitonin and 0.4 mM Myc peptide (Sigma-Aldrich). 
 
3-3-5 Liquid Chromatography-Tandem Mass Spectrometric Analysis 
(LC-MS/MS) 
In-gel trypsin digestion of protein bands of interest and LC-MS/MS mass 
spectrometric analysis (Orbitrap, Thermo Fisher Scientific, Waltham, MA, USA) were 
performed as previously described [80,81]. 
 
3-3-6 Tunicamycin treatment assay 
The tunicamycin treatment assay was performed as previously described [27]. 
HA-EhCdc50 expressing cells were treated with tunicamycin at 1, 3, 10 µg/mL, and 
incubated for 24 h at 35.5 °C. After incubation, cells were lysed and analyzed by 
immunoblotting with anti-HA, anti-EhCP-A5 and anti-EhVps26 antibodies. 
 
3-3-7 Production of EhCdc50 antibody 
The exoplasmic region of EhCdc50, corresponding to amino acid residues 108-271, 
was inserted into the pCold-GST vector (Takara Bio, Shiga, Japan). EhCdc50108-271 
recombinant protein was expressed in the Escherichia coli BL21 (DE3) strain 
(Thermo Fisher Scientific) and purified according to the manufacturer’s instructions. 
Anti- EhCdc50 antiserum was commercially raised against recombinant 
EhCdc50108-271 in rabbits (Eurofins Genomics, Val Fleuri, Luxembourg).  
 
3-3-8 Indirect immunofluorescence assay 
An indirect immunofluorescence assay was conducted essentially as previously 
described [26]. Trophozoites were seeded into 8-mm round wells on a glass slide, fixed 
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with 3.7% paraformaldehyde, permeabilized with 0.1% Triton X-100 and reacted with 
antibodies. Alexa 488- or Alexa 568-conjugated anti-mouse or rabbit IgG (Molecular 
Probes, Eugene, OR, USA) were used as secondary antibodies. Images were acquired 
using an LSM780 confocal laser-scanning microscope (Zeiss, Oberkochen, Germany). 
Images were analyzed using Zeiss ZEN software. 
 
3-3-9 Miltefosine sensitivity assay 
Trophozoites were seeded into 96-well plates at 0.5 × 104 cells/well in 280 µL of 
BI-S-33 medium containing 5–80 µM Miltefosine. After 18 h of culture, the medium 
was removed and the viability of attached trophozoites was estimated by measuring 
of the absorbance at 450 nm using a DTX880 Multimode Detector (Beckman Coulter, 
Brea, CA, USA) after incubating of the trophozoites with 100 µL of Opti-MEM 
medium containing 10% WST-1 reagent (Roche, Basel, Switzerland) for 20 min at 
37 °C [82]. Experiments were repeated three times with triplicate samples evaluated 
in each experiment. 
 
3-3-10 Phagocytosis assay 
Approximately 1 × 105 trophozoites of HA-EhCdc50 expressing and mock 
transformants were seeded on an 8-mm round wells slide glass. After removal of 
unattached trophozoites, 30 µL of PKH26 red fluorescent-labeled (Sigma) 
erythrocytes at 107 cells/mL were added to the trophozoites to allow phagocytosis for 
30 min. The samples were fixed and stained with HA-antibody followed by 
visualization with anti-mouse Alexa 488 antibody. The fluoresce intensity of PKH26 
incorporated by the HA-EhCdc50 expressing and mock tranformant trophozoites was 
measured on an LSM780 confocal microscope (Carl Zeiss) and analyzed with ZEN 
software (Carl Zeiss). 
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3-4 Results 
3-4-1 Identification of EhCdc50 as an EhRab8A interacting protein in E. 
histolytica  
 Previously I demonstrated that EhRab8A is localized to the ER in the steady state, 
which differs from the Rab8 ortholog in other organisms [38]. In mammals, Rab8 is 
localized to the trans-Golgi or endocytic compartments and involved in transport to 
the plasma membrane [38]. However, the function of the Golgi apparatus and the 
trans-Golgi in Entamoeba is highly diverse in protein glycosylation and organelle 
function [18]. Curiously, EhRab8A gene silencing demonstrated that EhRab8A is 
involved in the trafficking of at least three surface proteins with molecular masses of 
200, 60 and 30 kDa. In general, the protein sorting of secretory proteins in the ER is 
known to be regulated by the Sar1 GTPase but not by Rab GTPases [83]. To clarify the 
mechanisms of the EhRab8A-dependent trafficking across the ER, I attempted to 
identify EhRab8A interacting proteins by coimmunoprecipitation of the 
epitope-tagged EhRab8A.  
 To see whether EhRab8A forms a stable complex with other proteins and, if so, to 
estimate its apparent molecular mass, I conducted BN-PAGE following 
immunoprecipitation (Fig. 9A). Immunoblotting with the anti-Myc antibody revealed 
an 87-kDa band in the immunoprecipitated sample from lysates of N-terminal 
Myc-tagged EhRab8A-expressing cells (Fig. 9A, arrowhead), suggestive of possible 
interacting protein(s). The putative EhRab8A interacting protein(s) that were 
coimmunoprecipitated with Myc-EhRab8A using an anti-Myc antibody were detected 
as two specific bands of approximately 35 and 40 kDa (Fig. 9B, arrowheads). The two 
bands were excised from the gel and analyzed by liquid chromatography and 
time-of-flight tandem mass spectrometry (LC-ToF MS/MS) (Table 1, 2). From the 35 
kDa band, two candidate proteins, EHI_142740 and EHI_118780, were detected. 
EHI_142740 was detected exclusively from Myc-EhRab8A expressing cells but not 
from mock control cells. This protein showed homology with human CDC50 (33% 
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identity, e-value 1.3 × 1033) and Leishmania Cdc50 homologue, Los3 (25% identity, 
e-value 3.0 × 1025), which are known as a non-catalytic subunit of lipid flippase 
P4-ATPase. Thus, I designated hereinafter EHI_142740 as EhCdc50 (GenBank 
Accession number, LC389589). The other candidate detected in the 35 kDa band, 
EHI_118780, showed homology to a nuclear pore protein. From the 40 kDa band, six 
candidate proteins involved in lipid metabolism were identified: sphingomyelin 
phosphodiesterase (EHI_100080), glycerophosphodiester phosphodiesterase 
(EHI_068320), cytosolic tldc domain-containing protein (EHI_134660), C2 domain 
containing protein (EHI_069950), lysosomal vacuolar ATP synthase subunit 
(EHI_106350) and mitosome luminal protein sulfate adenylyltransferase 
(EHI_197160). Among these candidates, only glycerophosphodiester 
phosphodiesterase (EHI_068320) is known to be localized to the ER membrane in 
other organisms and thus considered to be a candidate of EhRab8A binding protein. 
However, the localization and function of the 40 kDa band as a potential EhRab8A 
interacting protein and the binding of these proteins to EhRab8A remain elusive, 
because I failed to establish amoeba transformants expressing EHI_068320 despite 
my repeated attempts. 
 
3-4-2 Confirmation of binding of EhCdc50 and EhRab8A 
 The interaction of EhCdc50 and EhRab8A was confirmed by reciprocal 
coimmunoprecipitation of EhRab8A from N-terminal HA-tagged-EhCdc50-expressing 
cells (Fig. 9C). The immunoprecipitated HA-EhCdc50 was recognized as a 42.5 kDa 
band using an anti-HA antibody; the size was slightly larger than the calculated 
molecular mass of HA-EhCdc50 of 38.9 kDa. This is consistent with the prediction 
that Cdc50 is a glycosylated transmembrane protein (see below). EhRab8A was 
detected as a 23 kDa band with anti-EhRab8A antiserum in the 
coimmunoprecipitated sample, while the negative control marker for endosomal 
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protein EhVps26 [27], which was previously shown to be differentially localized from 
EhRab8A, was not detected in the sample. These data clearly validated the physical 
interaction between EhRab8A and EhCdc50.  
 
3-4-3 EhCdc50 is N-glycosylated protein 
 The Cdc50 proteins are structurally well conserved at the primary sequence levels 
throughout eukaryotes and contain two transmembrane domains separated by a large 
exoplasmic loop (Fig. 11A, see below), which contains two to four N-glycosylation sites 
[Asn-Xaa-(Ser/Thr)] in Arabidopsis thaliana, Saccharomyces cerevisiae and human 
[84-86]. In human Cdc50A and S. cerevisiae Cdc50p, it has been demonstrated that 
post-translational modifications at the four N-glycosylation sites are necessary for the 
stable expression of lipid flippase P4-ATPase, complex formation and trafficking from 
the ER [85,86]. In E. histolytica, sequence-based prediction suggested that three of 
four N-glycosylation sites are present in the ectodomain (Asn141, Asn162 and 
Asn244) (Fig. 12A). Inhibition of N-glycosylation by tunicamycin treatment decreased 
the apparent molecular weight of HA-EhCdc50 from 42.5 kDa to 37.8 kDa, as shown 
by immunoblot analysis using an anti-HA antibody (Fig. 10), indicating that EhCdc50 
is modified with N-linked oligosaccharides. 
 
3-4-4 Localization of EhCdc50 and the inhibition of its transport to the 
plasma membrane by overexpression  
 Cdc50 is known as a non-catalytic subunit of lipid flippase P4-ATPase and the 
complex localizes to the endosomes and plasma membrane in the steady state [87]. 
Gene silencing of EhCdc50 was unsuccessful despite my repeated transfections, 
indicating EhCdc50 is essential for the growth. To investigate the localization of 
endogenous and exogenously overexpressed EhCdc50, I established a native antibody 
against recombinant EhCdc50108-271 (Fig. 11A). EhCdc50 was detected on the cell 
surface in the mock transformant with this anti-EhCdc50 antibody (similar results 
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were observed in wild type cells; data not shown) when trophozoites were not treated 
with Triton X-100, suggesting that endogenous EhCdc50 was uniformly distributed on 
the entire plasma membrane (Fig. 11B). The surface labeling by anti-EhCdc50 
antibody was significantly reduced when recombinant EhCdc50108-271 protein was 
used for competition; the relative intensity of the peripheral staining by anti-EhCdc50 
antibody was reduced to 19 ± 12% of the level in the absence of recombinant 
EhCdc50108-271 protein by the preincubation of the anti-EhCdc50 antibody with 
recombinant EhCdc50108-271 protein (Fig. 11B, C), validating specificity of this 
antibody against EhCdc50. I next examined the localization of EhCdc50 in 
HA-EhCdc50-expressing cells using an anti-EhCdc50 antibody. In 
HA-EhCdc50-expressing cells, EhCdc50 was not detected on the cell surface of the 
nonpermeabilized trophozoites with ani-EhCdc50 antibody (Fig. 11B, right panel), 
suggesting that transport of both HA-EhCdc50 and native EhCdc50 to the plasma 
membrane was prevented. When HA-EhCdc50 cells were perforated with Triton 
X-100, HA-EhCdc50 appeared to be associated with the ER-like network structures 
(Fig. 4A, upper panel), which was confirmed by co-staining with an anti-EhBip (ER 
luminal chaperone) antibody (Fig. 13A). HA-EhCdc50 showed strong colocalization 
with EhBip (Pearson’s correlation coefficient: R = 0.65). HA-EhCdc50 also showed 
mild colocalization with EhRab8A, as visualized using anti-HA and anti-EhRab8A 
antibodies (R = 0.47) (Fig. 13B). Colocalization of EhRab8A and EhBip was previously 
demonstrated with a Pearson’s correlation coefficient of 0.7. These results indicate 
that overexpressed HA-EhCdc50 is mainly localized to the ER and partially 
colocalized with EhRab8A. Similar observations suggesting that overexpressed Cdc50 
was accumulated in the ER were reported in other organisms including human and 
yeast [78,88]. 
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3-4-5 Overexpression of EhCdc50 or gene silencing of EhRab8A showed 
decreased miltefosine susceptibility 
 Many of phospholipid flippase P4-ATPases require interactions with the Cdc50 
family for their exit from the ER [88]. In Arabidopsis, S. cerevisiae and mammalian 
cells, either overexpression or knockout of Cdc50 caused accumulation of Cdc50 
together with P4-ATPase to the ER, which led to defects in the internalization of 
phospholipids [78,88]. I hypothesized that EhCdc50 and a catalytic subunit of 
phospholipid flippase P4-ATPase on the plasma membrane are involved in 
translocation of phospholipids from the exoplasmic to the cytoplasmic face in E. 
histolytica. The effect on phospholipid translocation in EhCdc50-overexpressing cells 
was evaluated using the phosphocholine analogue miltefosine, which is toxic and 
causes amebic cell growth inhibition. Miltefosine is an alkylated phosphocholine, 
originally developed as an anticancer drug and is effective against six different 
Leishmania species, including L. donovani, L. aethippoca, L. tropica, L. mexicana, L. 
panamensis and L. major. It has been shown in Leishmania that the deletion of the 
Cdc50 homologue, LdRos3, confers resistance to miltefosine [89]. I examined the 
susceptibility of an HA-EhCdc50-expressing strain against miltefosine. After 18-h 
treatment with miltefosine, the cell viability of the HA-EhCdc50 expressing strain 
was higher than that of the control mock transformant (The IC50 values of mock and 
HA-EhCdc50-expressing strains against miltefosine, 22.2 ± 3.2 and 33.4 ± 4.4 µM, 
respectively; p value <0.05) (Fig. 14A). Similarly, the EhRab8A gene-silenced strain 
showed partial resistance to miltefosine (The IC50 values of G3 parental and EhRab8A 
gene silenced strains were 21.8 ± 3.6 and 29.2 ± 2.8 µM, respectively; p value <0.05) 
(Fig. 14B). 
 
3-5 Discussion 
3-5-1 Identification of EhCdc50 as EhRab8A binding protein 
 Cdc50 is an essential accessory protein for the exit of lipid flippase P4-ATPase from 
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the ER in yeast, Leishmania, human and plant [90]. In this study, I identified the 
non-catalytic subunit, EhCdc50, of lipid flippase as a binding protein of EhRab8A 
small GTPase. The interaction between EhRab8A and EhCdc50 was confirmed by 
reciprocal immunoprecipitation (Fig. 9) and immunofluorescence assay (Fig. 13) in 
the present study and appears to be a common feature conserved among eukaryotes. 
Rab8 appears to be highly conserved in eukaryotes including Opistokonta (Metazoa 
and fungi), Viridiplantae (A. thaliana) and Amoebozoa (E. histolytica and 
Dictyostelium discoideum) [62,13] but not in Trypanosomatidae (Leishmania and 
Trypanosoma) and some protozoan parasites that belong to the Alveolata 
(Plasmodium and Toxoplasma) [91,92]. However, EhRab8A is unique in that it resides 
in the ER, while in human macrophages and Dictyostelium, Rab8 homologues localize 
to phagosomes or endocytic compartments [75,76]. In E. histolytica, EhRab8A is 
involved in the transport of surface proteins involved in the cellular attachment and 
phagocytosis. Thus, identification of Cdc50 as a binding protein of Rab small GTPase 
is plausible, as the flippase and thus its non-catalytic subunit, must be specifically 
transported via an EhRab8A-dependent secretory pathway, although this has never 
been demonstrated in other organisms. 
 EhRab8A gene-silencing decreased amebic adhesion to host cells and reduced the 
presentation of major three surface proteins with apparent molecular weights of 200, 
60 and 30 kDa. As intrinsic EhCdc50 has a calculated molecular mass of 35 kDa, it 
does not seem to correspond to one of the three previously identified major surface 
proteins. This explains why the HA-EhCdc50 expressing strain, in which 
HA-EhCdc50 is accumulated in the ER (Fig. 13), did not show a defect in phagocytosis 
of erythrocytes (Fig. 14). Taken together, EhRab8A is likely involved in the transport 
of multiple proteins including EhCdc50 as well as three previously reported major 
surface proteins from the ER to the cell surface. 
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3-5-2 N-linked oligosaccharide modification and possible role of EhCdc50 
in the exit from the ER 
 It has been shown that in mammalian and yeast cells Cdc50 has an apparent 
molecular mass of 50–60 kDa, is glycosylated in the Golgi and presented on the cell 
surface [90]. In Entamoeba, EhCdc50 was detected as a band with an approximate 
molecular weight of 35 kDa by SDS-PAGE (Fig. 10), which is consistent with the 
estimated molecular mass of the polypeptide (35.7 kDa), suggesting that EhCdc50 is 
not glycosylated [93]. However, as EhCdc50 possesses two hydrophobic 
transmembrane domains, which are likely responsible for the aberrant mobility on 
SDS-PAGE and offsetting possible glycosylations. Indeed, tunicamycin treatment 
reduced the molecular mass of HA-EhCdc50 by approximately 4.7 kDa (Fig. 10), 
indicating that some of the three potential N-glycosylation sites in EhCdc50 (Fig. 12) 
may be glycosylated. This predicted addition of a relatively short sugar chain is likely 
explained by the fact that E. histolytica forms an unusual simple 1.8 kDa N-glycan 
precursor of Man5GlcNAc2 in the ER rather than the common 2.5 kDa 
Glc3Man9GlcNAc2, which is present in most animals, plants and fungi [93]. 
 N-glycosylation of Cdc50 is required for stability and activity of the Cdc50/ATPase 
complex in mammalian cells [86]. It is currently unclear whether N-glycosylation of 
EhCdc50 is necessary for the interaction with EhRab8A. The results of BN-PAGE and 
immunoblotting showed that EhRab8A formed an 87 kDa complex (Fig. 9A), 
suggesting that the ~110 kDa amoebic EhP4-ATPase, which is present as a family of 
11 proteins encoded in the genome (see below), is not part of the EhRab8A/EhCdc50 
complex. After EhRab8A recognizes EhCdc50 and completes its sorting in the ER, 
EhRab8A is presumably replaced by EhP4-ATPase and then the N-glycosylated 
EhCdc50/EhP4-ATPase complex can be transported to the plasma membrane. 
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3-5-3 A possible novel Rab8A-dependent and COPII-independent pathway 
for Cdc50 traffic 
 One of the assumed roles of Cdc50 is trafficking of P4-ATPase from the ER to the cell 
surface. As suggested by a previous proteome analysis of the COPII coat component in 
yeast, P4-ATPase Nep1p physically interacts with the COPII coat components Sec13p, 
Sec23p and Sec24p [94]. It has been also shown that yeast P4-ATPase Drs2p interacts 
with Sec23p [94]. Analogously, EhCdc50 appears to be transported in a similar 
manner as Sar1p GTPase and COPII. However, EhRab8A does not colocalize with the 
COPII component on the ER, indicating the presence of an unconventional 
COPII-independent and EhRab8A-dependent ER exit pathway in Entamoeba.  
 It has been reported in many organisms that both repression and overexpression of 
Cdc50 and/or P4-ATPase prevents correct targeting of the P4-ATPase/Cdc50 complex 
and results in accumulation of the complex in the ER, concomitant with the loss of the 
plasma membrane-associated lipid flippase activity [78,88,95]. With a few exceptions, 
the class 2 P4-ATPases, yeast P4-ATPase Neo1p and mammalian ATP9A and ATP9B, 
do not require the Cdc50 family. Yeast Neo1p forms a complex with the scaffolding 
protein Ysl2p [96] and mammalian ATP9A and ATP9B exit the ER to localize with the 
respective cell membranes in the absence of Cdc50 [97]. I observed the plasma 
membrane localization of EhCdc50 in the steady state (Fig. 11). In contrast to the 
single gene copy of EhCdc50, I found 11 potential P4-ATPase genes in the E. 
histolytica genome: EHI_141350, EHI_096620, EHI_135220, EHI_188210, 
EHI_174280, EHI_049640, EHI_197300, EHI_168260, EHI_024120, EHI_140130 and 
EHI_009460. Three of them, EHI_049640, EHI_168260 and EHI_197300, were 
classified as class 2 P4-ATPases, suggesting that the EhCdc50 and P4-ATPase in the 
amoebic genome and several P4-ATPases exit the ER via an EhCdc50-independent 
mechanism. 
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3-5-4 EhRab8A and EhCdc50 are involved in miltefosine sensitivity in 
Entamoeba  
 Miltefosine is known to inhibit choline-phosphate cytidylyltransferase involved in 
the phosphatidylcholine biosynthesis in mammalian cells, [98] and homologous 
proteins are present in Leishmania [99]. However, the leishmanicidal mode of action 
on miltefosine is not completely understood and most information regarding its 
properties was obtained from miltefosine-resistant parasites generated in vitro and 
clinical isolates. Miltefosine resistance in Leishmania occurs mainly through the 
reduction in drug incorporation associated with the introduction of mutations into the 
P4-ATPase miltefosine transporter, MT and Cdc50 homologue, LdLos3 (Perez-Victoria 
et al., 2006). The resistance mechanism is likely conserved among Leishmania species 
causing either cutaneous (L. amazonensis and L. major) or visceral (L. donovani) 
leishmaniasis  [100,101]. Here I showed that overexpression of HA-EhCdc50 caused 
defects in EhCdc50/P4-ATPase trafficking and a concomitant increase in the tolerance 
to miltefosine (Fig. 14), suggesting that EhCdc50 is involved in the transport of 
phospholipids and miltefosine by P4-ATPase. Additionally, down-regulation of 
EhRab8A similarly caused tolerance to miltefosine (Fig. 14B), supporting the 
prediction that EhRab8A is necessary for the transport of EhCdc50/P4-ATPase. My 
result indicates that any mutations in EhRab8A that affect the affinity with EhCdc50 
or an increase in the expression of EhCdc50 can confer resistance to miltefosine in 
Entamoeba. Thus, EhRab8A and EhCdc50 are of interest as potential mechanisms of 
drug resistance against miltefosine in case it is used in clinical cases in future. In the 
human fungal pathogen Cryptococcus, it is reported that Cdc50 is involved in its 
virulence as well as in drug resistance [102]. 
 The mechanisms of EhCdc50/P4-ATPase in phospholipid transport and the 
EhRab8A-mediated regulation of EhCdc50/P4-ATPase trafficking remain unclear in E. 
histolytica. E. histolytica possesses full capacity of de novo biosynthesis of 
phospholipids including phosphatidylcholine and phosphatidylethanolamine and the 
 
 
45 
ability to scavenge components from the environment under in vitro cultivation 
conditions [42]. Furthermore, Entamoeba possesses a list of lipid binding proteins in 
their genome [103,104]; one of such lipid transfer proteins, EhPCTP-L, was shown to 
bind phosphatidylserine and phosphatidic acid and localizes to the cell surface [105]. 
The catalytic P4-ATPase subunit of the phospholipid flipase responsible for 
miltefosine transport should be identified to better understand the molecular 
mechanisms of phospholipid transport on the plasma membrane and its involvement 
in drug resistant and pathogenesis in Entamoeba. 
 
3-6 Figure Legends 
Fig. 9. Identification and confirmation of EhCdc50 as an EhRab8A binding 
protein 
A. Immunoblot analysis of Myc-EhRab8A with anti-Myc antibody following BN-PAGE 
from representative image of three independent experiments. B. SDS-PAGE analysis 
of Myc-EhRab8A-binding proteins. Myc-EhRab8A-binding proteins 
coimmunoprecipitated with anti-Myc antibody were separated on SDS-PAGE and 
detected with silver staining. Representative data of three independent experiments 
was shown. C. Reciprocal coimmunoprecipitation of EhRab8A via interaction with 
EhCdc50. EhCdc50 binding protein was immunoprecipitated from lysates of 
HA-EhCdc50-expressing cells with anti-HA antibody, followed by immunoblotting 
with anti-HA, anti-EhRab8A and anti-EhVps26 antibodies. Anti-EhVps26 antibody 
was used as a negative control. 
 
Fig. 10. Demonstration of N-linked glycosylation on EhCdc50  
HA-EhCdc50 expressing cells were treated with tunicamycin at 1, 3, 10 µg/mL for 24 
h. Cells were lysed and analyzed by immunoblotting with anti-HA, anti-EhCP-A5 and 
anti-EhVps26 antibodies. The apparent molecular weight of HA-EhCdc50 was 
decreased by the tunicamycin treatment. EhCP-A5 and EhVps26 are the glycosylated 
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and non-glycosylated proteins, respectively. 
 
Fig. 11. Surface staining of endogenous EhCdc50 in wild-type and 
overexpressed HA-tagged EhCdc50 cells 
A. Schematic diagram of the domain organization of EhCdc50. TMD, transmembrane 
domain. A part of the exoplasmic domain (a.a. 108–271) that was used to produce E. 
coli recombinant protein to raise antiserum is indicated with a dotted arrow. B. 
Indirect immunofluorescence assay of endogenous EhCdc50 in mock control and 
HA-tagged EhCdc50-expressing cells without permeabilization with Triton X100. 
Pretreatment of the EhCdc50 antiserum with the recombinant protein (middle panel) 
abolished the surface labeling. Scale bar, 5 µm. C. Quantification of surface labeling 
with anti-EhCdc50 antibody shown in B. Peripheral signal intensity of 30 
independent trophozoites was captured by Zeiss ZEN software. Bar graph shows the 
means and standard deviations of the relative peripheral fluorescence intensity of 
EhCdc50 with or without preincubation of the anti-EhCdc50 antibody with 
recombinant EhCdc50108-271 protein at a molar ratio of 1:100 in the mock and 
HA-EhCdc50 expressing cells, of three independent experiments. 
 
Fig. 12. Amino acid sequence alignment of Cdc50 homologues  
A. Sequences were aligned using ClustalW2 server 
(https://www.ebi.ac.uk/Tools/msa/clustalw2/). Accession numbers were: E. histolytica 
EhCdc50 (EHI_142740), human CDC50A (Q9NV96), S. cerevisiae Cdc50p (YCR094W), 
L. donovani LdRos3 (ABB05176) and A. thaliana ALIS5 (Q8L8W0). N-glycosylation 
sites of EhCdc50 were predicted using NetNGlyc 1.0 Server 
(http://www.cbs.dtu.dk/services/NetNGlyc/) and depicted with black arrowheads. 
N-glycosylation sites of Cdc50 homologues reported in humans, S. cerevisiae and A. 
thaliana, are indicated with small black crosses. Two transmembrane regions of 
EhCdc50 were predicted with the TMHMM Server v.2.0 
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(http://www.cbs.dtu.dk/services/TMHMM/) and depicted with red lines and “TMD.” B. 
Amino acid percentage identity matrix was created using the ClustalW2 server. 
 
Fig. 13. Immunofluorescence assay showing ER localization of 
overexpressed HA-EhCdc50 
HA-EhCdc50 expressing trophozoites were stained with anti-Bip (A, red), 
anti-EhRab8A (B, red) and anti-HA (green) antibodies (top panels) after 
permeabilization with Triton X100. Histograms of the green and red signal intensities 
along the line indicated in the merged images are shown in the bottom left panels. R = 
Pearson’s correlation coefficient. Bars, 5 µm. 
 
Fig. 14. Miltefosine sensitivity of EhCdc50 overexpressing and EhRab8A 
gene silencing cells 
A. Miltefosine sensitivity of EhCdc50 overexpressing cell. Percentage survival of 
HA-EhCdc50 expressing line and its corresponding mock transfected controls of HM-1 
after treatment with indicated concentrations of miltefosine for 18 h. B. Miltefosine 
sensitivity of EhRab8A gene silencing cell. Percentage survival of EhRab8A gene 
silenced line and its corresponding mock transfected controls of G3 strains. 
Calculated IC50 values using GraphPad Prism ver.6 software are also shown in the 
right panel. Bar graph shows the means and standard deviations of three 
independent experiments. The correlation coefficients were calculated using Student’s 
t-test. 
 
Fig. 15. Effect of HA-EhCdc50 overexpression on erythrophagocytosis 
Efficiency of erythrophagocytosis by the transformants expressing HA-EhCdc50, and 
mock transformant. The total fluorescence intensities of the PKH26-labeled 
erythrocytes ingested by a single trophozoite were measured, and the average of the 
total fluorescence intensities per trophozoite for each strain are shown.  
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Table 1. Thirty-five kDa proteins coimmunoprecipitated with Myc-EhRab8A. 
Annotation Gene ID  
Molecular 
Weight 
(kDa) 
Normalized Relative 
Ratio against 
Common Peptides, 
mock/mycRab8A 
Subcellular Localization in 
Other Organisms  
E-Value 
(Species) 
Cdc50 EHI_142740 36 0/2.68 trans-Golgi/endosome/PM/ER 
1.3 × 10−43 
(Arabidopsis 
thaliana) 
Nuclear 
pore protein EHI_118780  38 2.80/9.36 nucleus 
5.8 × 10−18 
(Chaetomiu 
thermopholum) 
 
Table 2. Forty kDa proteins coimmunoprecipitated with Myc-EhRab8A. 
Annotation Gene ID  
Molecular 
Weight 
(kDa) 
Normalized Relative 
Ratio against Common 
Peptides, 
mock/mycRab8A 
Subcellular 
Localization in 
Other 
Organisms  
E-Value 
(Species) 
Sphingomyelinase 
phosphodiesterase EHI_100080 46 0/1.02 Acid organella  
1.4 × 10−39 
(Dictyostelium 
discoideum) 
tldc domain-containing 
protein  EHI_134660  42 0/1.01 cytosol 
4 × 10−7 
(Heterostelium 
album) 
Vacuolar ATP synthase 
subunit  EHI_106350 40 0/1.01 
lysosome 
membrane 
1.3 × 10−100 
(Dictyostelium 
discoideum) 
Sulfate 
adenylyltransferase EHI_197160  48 0/1.01 
amoebic 
mitosome 
lumen 
8.8 × 10−141 
(Desulfovibrio 
desulfuricans) 
Glycerophosphodiester 
phosphodiesterase EHI_068320 45 0.84/2.02 ER  
4.6 × 10−25 
(Bacillus subtilis) 
C2 domain containing 
protein EHI_069950  37 4.19/9.09 cytosol 
5.1 × 10−7 
(Arabidopsis 
thaliana) 
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Chapter 4. General Discussion 
 In this study, I revealed that EhRab8A regulates protein transport on the ER 
membrane to the plasma membrane. This is the first report that the Rab GTPase, 
which is localized on the ER, regulates protein sorting at the ER. In general, protein 
sorting into the COPII vesicles from the ER is regulated by the Sar1 GTPase, During 
the formation of COPII-coated vesicles on the ER, Sar1 is activated by the ER integral 
membrane protein Sec12, which functions as Sar1 GEF. Membrane-bound Sar1-GTP 
recruits Sec23-Sec24 heterodimer, and Sec23/24-Sar1 complex selects transmembrane 
and cargo proteins, that are packed into the COPII vesicles [94]. Subsequently, 
Sec23-Sec24 heterodimer recruits Sec13-Sec31 heterodimer on to the prebudding 
complex, executing of the outer layer of the coat [106]. After completion of COPII coat 
assembly, Sec23 GAP activated GTP-hydrolysis of Sar1, and then vesicle uncoating 
occurs. The uncoated vesicle is finally fused with the cis-Golgi membrane by the 
regulation of Rab1 GTPase. Sar1 and all the component of COPII coat is conserved in 
Entamoeba, and I successfully detected with the ER budding site using anti-Sec13 
antibody. My result that the localization of EhRab8A was differed from COPII 
component Sec13 indicated that EhRab8A was localized to different subcompartment 
from COPII budding sites, implicating the presence of functionally distinct cargo 
sorting site by EhRab8A from EhSar1 in E. histolytica. Rab mainly controls 
membrane fusion with the target membrane, but only a few cases of Rab involved in 
cargo selection and sorting: human Rab5 sorts transferrin receptors into the 
clathrin-coated pits at the plasma membrane during the clathrin-mediated 
endocytosis [107]. This observation suggests that the EhRab8A is also involved in the 
cargo selection in the ER membrane independent from the Sar1 and COPII vesicles. 
 In addition, I discovered that the EhRab8A pathway is independent from EhRab11B 
regulated pathway in E. histolytica: EhRab8A localization was differed from 
EhRab11B. Rab cascade between Rab11 and Rab8, that is directed to the plasma 
membrane transport, is reported in other eukaryotes such as H. sapience, S. 
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cerevisiae, and D. discoideum. The cascade is that Rab11 effector, named Rabin8 in 
mammals, is Rab8 GEF, that is activated Rab11 subsequently activates Rab8 in the 
same pathway [74]. Interestingly, Entamoeba dose not possesses a homolog of Rabin8 
in their genome, supporting that EhRab8A plays a different roll from other organisms. 
In human cases, Rabin8 activates several isotypes of Rab GTPases, HsRab8, 
HsRab8B, and HsRab10, and also regulates several pathways, such as primary 
ciliogenesis and cystogenesis in other organisms. Besides of the lack of Rabin8 
homolog in E. histolytica, Rab10 is not conserved in Entamoeba and function of 
EhRab8B is not well elucidated. These observations indicated that the Rab GTPase 
function and transport pathways are diversified, and then the regulation system of 
Rab is also significantly altered in E. histolytica. 
 It is unresolved whether cargo proteins sorted by EhRab8A target to the Golgi and 
then modified with Golgi resident enzyme, but otherwise transport to the plasma 
membrane directly. It needs to identify the true effector or more cargo proteins of 
EhRab8A for the clarification of EhRab8A-dependent pathway. The EhRab8A binding 
protein, EhCdc50, reported in this study was modified with N-linked sugar, which is 
transferred to the EhCdc50 into the ER lumen. Currently, it is still unknown whether 
EhCdc50 is modified with Golgi resident glycosylation, that is only 
glycosyltransferase, galactosyl transferase in E. histolytica. My result also shows that 
EhRab8A regulates several surface proteins in addition to the EhCdc50, and those 
surface proteins might be involved in host cell attachment and phagocytosis. Thus, 
the identification of the additional cargo proteins will contribute to the understanding 
of amoebic virulence. In conclusion, the discovery of effector proteins will support the 
identification of the new transport pathway regulated by EhRab8A, and may 
contribute to the generation of new insights on eukaryotic membrane trafficking. 
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